2012: Year in review
Recent articles
What stood out to you in 2012?
We packaged the year’s research highlights from our vantage point. What advances stood out to you in 2012? And where do you see the field going?
What stood out to you in 2012?
We packaged the year’s research highlights from our vantage point. What advances stood out to you in 2012? And where do you see the field going?
Top tools and techniques of 2012
2012 saw many new exciting — and often colorful — technical advances, ranging from tools that build brains from the cell up to robots that can replace neuroscientists.
Top tools and techniques of 2012
2012 saw many new exciting — and often colorful — technical advances, ranging from tools that build brains from the cell up to robots that can replace neuroscientists.
Drugs in development for autism
A look at various drugs attempting to address autism and their stages of development.
Drugs in development for autism
A look at various drugs attempting to address autism and their stages of development.
Predictions for 2013
Take a look through SFARI.org’s crystal ball to predict major developments in autism research in 2013.
Predictions for 2013
Take a look through SFARI.org’s crystal ball to predict major developments in autism research in 2013.
Most-viewed articles of 2012
A list of the ten stories that most caught our readers’ attention this year.
Most-viewed articles of 2012
A list of the ten stories that most caught our readers’ attention this year.
Hot topics in 2012
New candidate genes, drugs in development and diagnostic debates were just a few of the themes that garnered intense interest this year.
Hot topics in 2012
New candidate genes, drugs in development and diagnostic debates were just a few of the themes that garnered intense interest this year.
Director’s column: 2012 in review
SFARI director Gerald Fischbach comments on the year’s most notable papers.
Director’s column: 2012 in review
SFARI director Gerald Fischbach comments on the year’s most notable papers.
Notable papers of 2012
Among a wealth of exciting research, ten sets of papers made an impact this year.
Notable papers of 2012
Among a wealth of exciting research, ten sets of papers made an impact this year.
Explore more from The Transmitter
To keep or not to keep: Neurophysiology’s data dilemma
An exponential growth in data size presents neuroscientists with a significant challenge: Should we be keeping all raw data or focusing on processed datasets? I asked experimentalists and theorists for their thoughts.
To keep or not to keep: Neurophysiology’s data dilemma
An exponential growth in data size presents neuroscientists with a significant challenge: Should we be keeping all raw data or focusing on processed datasets? I asked experimentalists and theorists for their thoughts.
Neuroscientists reeling from past cuts advocate for more BRAIN Initiative funding
The director of the U.S. National Institutes of Health calls BRAIN a “high priority” but acknowledges that difficult decisions lie ahead if federal budgets remain flat.
Neuroscientists reeling from past cuts advocate for more BRAIN Initiative funding
The director of the U.S. National Institutes of Health calls BRAIN a “high priority” but acknowledges that difficult decisions lie ahead if federal budgets remain flat.
‘Huge influx’ of neuroscientists migrates to Bluesky
Daily neuroscience-related posts on the social-media platform this week have increased more than 400 percent, on average, compared with October.
‘Huge influx’ of neuroscientists migrates to Bluesky
Daily neuroscience-related posts on the social-media platform this week have increased more than 400 percent, on average, compared with October.